We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
26 hedge funds and large institutions have $19.5M invested in Zevra Therapeutics in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 9 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
13% less funds holding
Funds holding: 30 → 26 (-4)
17% less capital invested
Capital invested by funds: $23.4M → $19.5M (-$3.91M)
33% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 9
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
57% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 7
Holders
26
Holders Change
-4
Holders Change %
-13.33%
% of All Funds
0.65%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
3
Increased
6
Reduced
9
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
DA
DSC Advisors
Chicago,
Illinois
|
+$1.11M |
| 2 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$184K |
| 3 |
CWG
C WorldWide Group
Copenhagen,
Denmark
|
+$179K |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$59K |
| 5 |
VF
Virtu Financial
New York
|
+$48.1K |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
-$2.82M |
| 2 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$640K |
| 3 |
PL
Parkwood LLC
Cleveland,
Ohio
|
-$503K |
| 4 |
NWM
Northwest Wealth Management
Spencer,
Iowa
|
-$83K |
| 5 |
Goldman Sachs
New York
|
-$71K |
